Obesity, diabetes mellitus, and liver fibrosis. - Wikidata - awgldk - TriplyDB

Obesity, diabetes mellitus, and liver fibrosis.

Obesity, diabetes mellitus, and liver fibrosis.

http://www.wikidata.org/entity/Q34979922

about

Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step Kupffer cells in the liver Regulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effect Amylin at the interface between metabolic and neurodegenerative disorders Non-alcoholic fatty liver disease: need for a balanced nutritional source Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring Sonographic assessment of fatty liver: intraobserver and interobserver variability.Evolving therapies for liver fibrosis.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism.Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.Non-alcoholic fatty liver disease, diet and gut microbiota.The VASP Road to NAFLD: A Macrophage Detour High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Alleviation of Carbon-Tetrachloride-Induced Liver Injury and Fibrosis by Betaine Supplementation in Chickens Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice.Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines.Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model Park Density Impacts Weight Change in a Behavioral Intervention for Overweight Rural Youth.Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver.Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.Oxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies.Liver and diabetes. A vicious circle.Relaxin treatment reverses insulin resistance in mice fed a high-fat diet Relationships between diabetes and cognitive impairment Hepatic transcriptome implications for palm fruit juice deterrence of type 2 diabetes mellitus in young male Nile rats.Downregulation of sulfotransferase expression and activity in diseased human livers.Effects of acute exercise and chronic exercise on the liver leptin-AMPK-ACC signaling pathway in rats with type 2 diabetes.Severely obese adolescents and adults exhibit a different association of circulating levels of adipokines and leukocyte expression of the related receptors with insulin resistance.Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.Cdc2-like kinase 2 suppresses hepatic fatty acid oxidation and ketogenesis through disruption of the PGC-1α and MED1 complex.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

P2860

Q26769609-E1878480-BB47-456F-ADE3-8C165CF6F745 Q26771518-C6533F57-30F8-404A-9A5B-BC2EBEDA9674 Q26822031-0079523D-DB83-477F-9736-0F9F3EBF08A2 Q26827829-2F019646-0F81-4399-B3B6-F0FF049B1593 Q27003342-AE940728-FB76-4282-98AF-4885F1DB63A2 Q28248994-5DE9A4FF-AF53-448C-BFCF-46152BA70CAD Q28539372-CDDD544C-73FC-43B8-BFAD-B5BD660D0474 Q30419242-4068BE35-28C2-443F-9804-8762CF3CD584 Q30539166-281482BE-5C73-41B5-A369-633F39740B73 Q34288447-D544DAE7-5876-4F7A-9FFE-E00401004A28 Q34449413-EDB988ED-777E-4487-B8B4-5507B13F47D7 Q34600849-0833EBB9-D70D-4F62-852F-6FE4F0242008 Q35209849-0BBBBAEC-9059-4A7C-9BC1-14835A0C055F Q35260692-D78CB1CA-409D-49BA-881E-7CEFBBD6C26A Q35550630-7B8A7640-90EC-4E21-A00B-8F3ECD997E49 Q35720450-392A52D3-2848-4D09-9215-A8E0BC4DDF01 Q35728214-508306BC-7215-4591-8D74-DCA28C4236D1 Q35881766-74D3E9E5-BA0F-4D97-B519-7DAB84FE381B Q35958233-F030C851-3DFC-4686-9982-22E7A7472F5A Q35997881-C31C3FF1-5E35-4CE7-A48F-75CDD82F4061 Q35997884-1102D718-2D37-4746-AB26-9FE35B5C8416 Q36042132-BBD9C3B1-9CE1-4C37-9021-03B867CC059B Q36145165-0D3F60B9-3AA8-49FD-9BA2-9E2AB457AB7F Q36156379-1A0E07B3-259A-4510-AB24-E647C01629E4 Q36431902-C4A0B5F0-A924-496E-B78F-6B3B943A515F Q36492869-6D1C4E2D-BEA7-4F57-8E95-2AA1AFA83205 Q36497224-6EB79E46-422A-4AE3-A5AA-82BFDE124702 Q36551969-5F4707AB-A28D-47A1-B111-17059B5E2983 Q36705993-8B1F956F-495B-41EC-A8BE-1920EDB29F57 Q36949957-F1083C68-EF00-4EE0-8FE7-527E12DEAEB4 Q37070333-44934F86-931E-4276-B435-B4D2AFAE6C37 Q37110579-9A3D0269-77B7-40E4-B30E-C34628B26699 Q37162219-6FD2E533-F6FF-4B2F-8BB4-A316FAFD9283 Q37358926-642D3075-AA82-4692-9EF1-DA779D96F932 Q37422741-C7FDC5DC-A4B7-4A80-8BEA-2FF35B2859F8 Q37424332-48B2C6D7-F0AB-4FF2-8FCA-44A308BDF996 Q37433030-B38ECDA5-3B25-4C4D-8A74-B9F3AE0AB8C2 Q37498674-9E1C67B1-A874-4BF3-9F97-8A74DBFE4A4E Q37715596-FA59B77D-5E0D-4F17-8643-FE4BB39B1D28 Q37978785-B20660E3-F6EB-411C-944F-631E1BAD1CB8

P2860

Obesity, diabetes mellitus, and liver fibrosis.

http://www.wikidata.org/entity/Q34979922

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Obesity, diabetes mellitus, and liver fibrosis.

@ast

Obesity, diabetes mellitus, and liver fibrosis.

@en

Obesity, diabetes mellitus, and liver fibrosis.

@nl

type

label

Obesity, diabetes mellitus, and liver fibrosis.

@ast

Obesity, diabetes mellitus, and liver fibrosis.

@en

Obesity, diabetes mellitus, and liver fibrosis.

@nl

prefLabel

Obesity, diabetes mellitus, and liver fibrosis.

@ast

Obesity, diabetes mellitus, and liver fibrosis.

@en

Obesity, diabetes mellitus, and liver fibrosis.

@nl

P1433

Q34979922-2D35D4F0-3DC4-4AC7-AC02-E1A4F0071403

P1476

Q34979922-4BF7DC0E-85D2-44C5-B0DE-AAF63107D486

P2093

Q34979922-4A53117B-7181-4E4A-8E70-494C1A8B0CD0

Q34979922-4CA14294-1525-4AA4-B844-0C09606135BE

P2860

Q34979922-0253E37C-16CE-47E8-9E88-C850E45E51DC

Q34979922-025D20A2-205F-43B5-8313-43AAC66D8D57

Q34979922-028986FA-DB62-474C-9EF9-F4CF412485DC

Q34979922-043BB851-89D4-4A7D-859A-4438A6C156A6

Q34979922-054658C3-275A-4CB7-B78C-FA8798A4E64A

Q34979922-0585808C-D5D1-43D9-B48A-B1E19BD64175

Q34979922-0A7E61F5-B978-4636-8261-ABE31028B75A

Q34979922-0B93B39D-E760-4E98-B554-428D1BE16951

Q34979922-0F212229-3F54-4462-926E-59C5016ACBF4

Q34979922-1ABC5005-C297-43F8-88FA-FD8E5CE18FF2

P304

Q34979922-B7990782-6BEF-44D1-8E55-7498D6D4F5FD

P31

Q34979922-34B8D6FA-1EAC-4C21-A653-B732DAFCAD95

P356

Q34979922-03730163-1629-443B-9BCA-C9640B4DCC75

P433

Q34979922-87E4AFC5-1C53-42D6-91CC-33CEC7CFC09B

P478

Q34979922-2C144504-A899-4F87-B752-5BD21E17A43A

P50

Q34979922-DA241BBC-B35F-4F5D-8AEF-E463CF4D3A8F

P577

Q34979922-87F7448D-35A1-4223-8473-FFED483838D8

P5875

Q34979922-97A45506-F327-4CF0-93C0-CC5964DF7B09

P698

Q34979922-453F70BB-4696-4570-ABCB-0DCAB4431541

P921

Q34979922-B5B9B12E-568E-4EE5-AAA6-1BFFB8FD39B1

P932

Q34979922-0F223717-AD5B-4A36-81EE-84F7CAFC1CD0

P356

AJPGI.00426.2010

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Obesity, diabetes mellitus, and liver fibrosis.

@en

P2093

Dian J Chiang

http://www.w3.org/2001/XMLSchema#string

Laura E Nagy

http://www.w3.org/2001/XMLSchema#string

P2860

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes

Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study

P304

G697-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00426.2010

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P50

Michele T Pritchard

P577

2011-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50196230

http://www.w3.org/2001/XMLSchema#string

P698

21350183

http://www.w3.org/2001/XMLSchema#string

P921

P932

3094133

http://www.w3.org/2001/XMLSchema#string